Patents by Inventor Jeremy B. Tuttle

Jeremy B. Tuttle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating hyperactive voiding with calcium channel blockers
    Patent number: 5698549
    Abstract: The instant invention discloses a method of treating hyperactive voiding associated with excessive nerve growth factor production and nerve growth in patients by administering a Ca.sup.++ channel blocker. The Ca.sup.++ channel blockers verapamil and diltiazem can be administered systemically to treat hyperactive voiding, such as is associated with benign prostatic hyperplasia and interstitial cystitis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 16, 1997
    Assignee: UVA Patent Foundation
    Inventors: William D. Steers, Jeremy B. Tuttle
  • Detection of urinary tract obstruction by nerve growth factor measurement in urine
    Patent number: 5503986
    Abstract: The method of detecting lower urinary tract disease is disclosed through the comparison of the concentration of a neurotrophic factor present in a urine specimen in comparison with a predetermined normal concentration. Nerve growth factor, having a concentration of approximately less than 8 picograms per milliliter is the preferred factor. The concentration of nerve growth factor in the urine rises at the onset of the lower urinary tract disease and decreases as said disease progresses. Nerve growth factor production and nerve growth is inhibited by administering the Ca.sup.++ channel blockers, verapamil or diltiazem.
    Type: Grant
    Filed: May 12, 1994
    Date of Patent: April 2, 1996
    Assignee: University of Virginia Patent Foundation
    Inventors: William D. Steers, Jeremy B. Tuttle